Peg-intron and Heparin drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported only by a few people who take Peg-intron and Heparin together.

The phase IV clinical study analyzes what interactions people who take Peg-intron and Heparin have. It is created by eHealthMe based on reports of 2 people who take the same drugs from the FDA, and is updated regularly.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.



On Oct, 03, 2022

2 people who take Peg-intron and Heparin together, and have interactions are studied.


What is Peg-intron?

Peg-intron has active ingredients of peginterferon alfa-2b. eHealthMe is studying from 11,142 Peg-intron users for its effectiveness, alternative drugs and more.

What is Heparin?

Heparin has active ingredients of heparin sodium. eHealthMe is studying from 81,999 Heparin users for its effectiveness, alternative drugs and more.

Number of Peg-intron and Heparin reports submitted per year:

Peg-intron and Heparin drug interactions.

Common Peg-Intron and Heparin drug interactions by gender *:

female:

  1. Ascites
  2. Hepatic encephalopathy
  3. Hepatic failure

male:

  1. Angiodysplasia
  2. Chest pain
  3. Decreased activity
  4. Deep vein thrombosis
  5. Gastrointestinal amyloidosis
  6. Gastrointestinal haemorrhage
  7. Haemorrhoids
  8. Neoplasm progression
  9. Pulmonary embolism
  10. Rectal haemorrhage

Common Peg-Intron and Heparin drug interactions by age *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

  1. Neoplasm progression
  2. Pulmonary embolism
  3. Rectal haemorrhage
  4. Angiodysplasia
  5. Chest pain
  6. Decreased activity
  7. Deep vein thrombosis
  8. Gastrointestinal amyloidosis
  9. Gastrointestinal haemorrhage
  10. Haemorrhoids

60+:

  1. Ascites
  2. Hepatic encephalopathy
  3. Hepatic failure

* Approximation only. Some reports may have incomplete information.

Do you take Peg-intron and Heparin?

Personalize this study to your gender and age

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.



Related studies

Alternative drugs to, pros and cons of the 2 drugs:

Browse all drug interactions of Peg-intron and Heparin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Peg-intron interactions:

Browse all interactions between Peg-intron and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Heparin interactions:

Browse all interactions between Heparin and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on peginterferon alfa-2b and heparin sodium (the active ingredients of Peg-intron and Heparin, respectively), and Peg-intron and Heparin (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study. Patients in the study may take other drugs besides Peg-intron and Heparin.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: